Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Intas
Pharma
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
AZ licensed a KRAS G12D drug from Usynova. BeiGene bought a CDK2 inhibitor from Ensem. Coherus priced its Chinese PD-1 at a 20% discount to Keytruda.
Angus Liu
Dec 1, 2023 8:34am
FDA put Intas plant on import alert, warning letter shows
Nov 29, 2023 1:26pm
AbbVie files patent litigation against generic Rinvoq makers
Nov 22, 2023 9:04am
Novartis-Legend, Astellas, Ajinomoto—Fierce Pharma Asia
Nov 17, 2023 8:00am
UK tribunal upholds £130M fine in hydrocortisone price hike case
Sep 19, 2023 3:55pm
Intas and other manufacturers hit with FDA warning letters
Aug 2, 2023 9:55am